153 related articles for article (PubMed ID: 17302880)
1. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function.
Fasshauer M; Blüher M; Stumvoll M; Tönessen P; Faber R; Stepan H
Clin Endocrinol (Oxf); 2007 Mar; 66(3):434-9. PubMed ID: 17302880
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
Savvidou MD; Sotiriadis A; Kaihura C; Nicolaides KH; Sattar N
Clin Sci (Lond); 2008 Oct; 115(7):219-24. PubMed ID: 18211260
[TBL] [Abstract][Full Text] [Related]
3. Plasma visfatin levels in preeclamptic and normal pregnancies.
Zulfikaroglu E; Isman F; Payasli A; Kilic S; Kucur M; Danisman N
Arch Gynecol Obstet; 2010 Jun; 281(6):995-8. PubMed ID: 19639329
[TBL] [Abstract][Full Text] [Related]
4. Perinatal circulating visfatin levels in intrauterine growth restriction.
Malamitsi-Puchner A; Briana DD; Boutsikou M; Kouskouni E; Hassiakos D; Gourgiotis D
Pediatrics; 2007 Jun; 119(6):e1314-8. PubMed ID: 17502346
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia.
D'Anna R; Baviera G; Corrado F; Giordano D; De Vivo A; Nicocia G; Di Benedetto A
BJOG; 2006 Nov; 113(11):1264-9. PubMed ID: 17010118
[TBL] [Abstract][Full Text] [Related]
6. Serum visfatin levels in late pregnancy and pre-eclampsia.
Hu W; Wang Z; Wang H; Huang H; Dong M
Acta Obstet Gynecol Scand; 2008; 87(4):413-8. PubMed ID: 18382866
[TBL] [Abstract][Full Text] [Related]
7. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of the adipokine visfatin are increased in pre-eclampsia.
Fasshauer M; Waldeyer T; Seeger J; Schrey S; Ebert T; Kratzsch J; Lossner U; Bluher M; Stumvoll M; Faber R; Stepan H
Clin Endocrinol (Oxf); 2008 Jul; 69(1):69-73. PubMed ID: 18034779
[TBL] [Abstract][Full Text] [Related]
9. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
[TBL] [Abstract][Full Text] [Related]
10. Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction.
Vasapollo B; Valensise H; Novelli GP; Larciprete G; Di Pierro G; Altomare F; Casalino B; Galante A; Arduini D
Ultrasound Obstet Gynecol; 2002 Nov; 20(5):452-7. PubMed ID: 12423481
[TBL] [Abstract][Full Text] [Related]
11. [Relationship of adiponectin and visfatin with fetus intrauterine growth].
Shang LX; Tang QL; Wang J; Zhang F; Wu N; Wang SH; Li P
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):246-8. PubMed ID: 19570458
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
[TBL] [Abstract][Full Text] [Related]
13. Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations.
Stadler M; Storka A; Theuer EA; Krebs M; Vojtassakova E; Nowotny P; Pacini G; Kästenbauer T; Luger A; Prager R; Wolzt M; Anderwald C
Clin Endocrinol (Oxf); 2010 Jun; 72(6):763-9. PubMed ID: 19769621
[TBL] [Abstract][Full Text] [Related]
14. Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction.
Rodie VA; Young A; Jordan F; Sattar N; Greer IA; Freeman DJ
J Soc Gynecol Investig; 2005 Jul; 12(5):320-9. PubMed ID: 15979543
[TBL] [Abstract][Full Text] [Related]
15. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies.
Cortelazzi D; Corbetta S; Ronzoni S; Pelle F; Marconi A; Cozzi V; Cetin I; Cortelazzi R; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2007 Mar; 66(3):447-53. PubMed ID: 17302882
[TBL] [Abstract][Full Text] [Related]
16. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients.
Haider DG; Schindler K; Mittermayer F; Müller M; Nowotny P; Rieger A; Luger A; Ludvik B; Wolzt M
Clin Pharmacol Ther; 2007 Apr; 81(4):580-5. PubMed ID: 17235334
[TBL] [Abstract][Full Text] [Related]
17. Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction.
Christians JK; Gruslin A
Prenat Diagn; 2010 Sep; 30(9):815-20. PubMed ID: 20658698
[TBL] [Abstract][Full Text] [Related]
18. Role of oxidative stress in intrauterine growth restriction.
Biri A; Bozkurt N; Turp A; Kavutcu M; Himmetoglu O; Durak I
Gynecol Obstet Invest; 2007; 64(4):187-92. PubMed ID: 17664879
[TBL] [Abstract][Full Text] [Related]
19. Second trimester amniotic fluid endothelin-1 concentrations and subsequent development of intrauterine growth restriction.
Margarit L; Griffiths AN; Tsapanos V; Tsakas S; Gumenos D; Decavalas G
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):192-5. PubMed ID: 17123690
[TBL] [Abstract][Full Text] [Related]
20. Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies.
Schiessl B; Strasburger C; Bidlingmaier M; Mylonas I; Jeschke U; Kainer F; Friese K
Arch Gynecol Obstet; 2006 Jun; 274(3):150-4. PubMed ID: 16532320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
